Please assess the completion status of the following clinical trial:

Trial Title: Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically proven (biopsy or cytology) NSCLC (SCC, Adenocarcinoma, Large Cell)~* TNM clinical non-operable stage I/II and non-resectable stage IIIa/b without pleural effusion~* Measurable disease~* No other malignancy, except non-melanomatous skin cancer, within 5 years prior to participation in this study; the disease-free interval from any prior carcinoma must be continuous~* Patient suitable for radical 3-DCRT~* ECOG-Performance status ≤ 2 / KPS \> or equal to 60~* Weight loss \<10% within the 3 months prior to diagnosis~* No prior radiotherapy to the thorax~* Patient is suitable for lung-board immobilisation~* No chemotherapy received prior to planning PET-CT scan~* Age 18 and over~* Provision of written informed consent~Exclusion Criteria:~* Evidence of any other significant clinical disorder or laboratory finding that makes it undesirable for the patient to participate in the trial or if it is felt by the research / medical team that the patient may not be able to comply with the protocol.~* FEV1 \< 1

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 3-DCRT (Type: EXPERIMENTAL): Patients will receive a total dose of 60-66 Gy in 30-33 fractions with 3-DCRT

Based on this trial design, predict the completion outcome and termination type (if applicable).